These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1059 related articles for article (PubMed ID: 18715415)

  • 1. A randomised controlled trial of early versus delayed oxytocin augmentation to treat primary dysfunctional labour in nulliparous women.
    Hinshaw K; Simpson S; Cummings S; Hildreth A; Thornton J
    BJOG; 2008 Sep; 115(10):1289-95; discussion 1295-6. PubMed ID: 18715415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early versus delayed oxytocin augmentation in nulliparous women with prolonged labour--a randomised controlled trial.
    Dencker A; Berg M; Bergqvist L; Ladfors L; Thorsén LS; Lilja H
    BJOG; 2009 Mar; 116(4):530-6. PubMed ID: 19250364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Start of induction of labour with oxytocin in the morning or in the evening. A randomised controlled trial.
    Bakker JJ; De Vos R; Pel M; Wisman C; Van Lith JM; Mol BW; Van Der Post JA
    BJOG; 2009 Mar; 116(4):562-8. PubMed ID: 19250367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two preparations of dinoprostone for pre-induction of labour in nulliparous women with very unfavourable cervical condition: a randomised clinical trial.
    Facchinetti F; Venturini P; Verocchi G; Volpe A
    Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):189-93. PubMed ID: 15808378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent oxytocin with dinoprostone pessary versus dinoprostone pessary in labour induction of nulliparas with an unfavourable cervix: a randomised placebo-controlled trial.
    Tan PC; Valiapan SD; Tay PY; Omar SZ
    BJOG; 2007 Jul; 114(7):824-32. PubMed ID: 17506788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Titrated low-dose vaginal and/or oral misoprostol to induce labour for prelabour membrane rupture: a randomised trial.
    Bricker L; Peden H; Tomlinson AJ; Al-Hussaini TK; Idama T; Candelier C; Luckas M; Furniss H; Davies A; Kumar B; Roberts J; Alfirevic Z
    BJOG; 2008 Nov; 115(12):1503-11. PubMed ID: 18752586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal misoprostol for induction of labour: a more effective agent than prostaglandin F2 alpha gel and prostaglandin E2 pessary.
    Majoko F; Zwizwai M; Nyström L; Lindmark G
    Cent Afr J Med; 2002; 48(11-12):123-8. PubMed ID: 14562597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial of amniotomy and immediate oxytocin infusion versus amniotomy and delayed oxytocin infusion for induction of labour at term.
    Selo-Ojeme DO; Pisal P; Lawal O; Rogers C; Shah A; Sinha S
    Arch Gynecol Obstet; 2009 Jun; 279(6):813-20. PubMed ID: 18958483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive or expectant management of labour: a randomised clinical trial.
    Pattinson RC; Howarth GR; Mdluli W; Macdonald AP; Makin JD; Funk M
    BJOG; 2003 May; 110(5):457-61. PubMed ID: 12742329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of labours augmented with oxytocin.
    Bugg GJ; Stanley E; Baker PN; Taggart MJ; Johnston TA
    Eur J Obstet Gynecol Reprod Biol; 2006 Jan; 124(1):37-41. PubMed ID: 15955617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbetocin versus syntometrine for the third stage of labour following vaginal delivery--a double-blind randomised controlled trial.
    Su LL; Rauff M; Chan YH; Mohamad Suphan N; Lau TP; Biswas A; Chong YS
    BJOG; 2009 Oct; 116(11):1461-6. PubMed ID: 19538418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women's experiences after early versus postponed oxytocin treatment of slow progress in first childbirth--a randomized controlled trial.
    Bergqvist L; Dencker A; Taft C; Lilja H; Ladfors L; Skaring-Thorsén L; Berg M
    Sex Reprod Healthc; 2012 Jun; 3(2):61-5. PubMed ID: 22578752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primiparas with or without oxytocin augmentation: a prospective descriptive study.
    Svärdby K; Nordström L; Sellström E
    J Clin Nurs; 2007 Jan; 16(1):179-84. PubMed ID: 17181680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is induced labour in the nullipara associated with more maternal and perinatal morbidity?
    Selo-Ojeme D; Rogers C; Mohanty A; Zaidi N; Villar R; Shangaris P
    Arch Gynecol Obstet; 2011 Aug; 284(2):337-41. PubMed ID: 20838800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of labor with oxytocin increases cesarean section rate as compared with oxytocin for augmentation of spontaneous labor in nulliparous parturients controlled for lumbar epidural analgesia.
    Kaul B; Vallejo MC; Ramanathan S; Mandell G; Phelps AL; Daftary AR
    J Clin Anesth; 2004 Sep; 16(6):411-4. PubMed ID: 15567643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planned caesarean section decreases the risk of adverse perinatal outcome due to both labour and delivery complications in the Term Breech Trial.
    Su M; Hannah WJ; Willan A; Ross S; Hannah ME;
    BJOG; 2004 Oct; 111(10):1065-74. PubMed ID: 15383108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misoprostol versus expectant management in premature rupture of membranes at term.
    da Graça Krupa F; Cecatti JG; de Castro Surita FG; Milanez HM; Parpinelli MA
    BJOG; 2005 Sep; 112(9):1284-90. PubMed ID: 16101609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation versus discontinuation of oxytocin infusion during the active phase of labour: a randomised controlled trial.
    Bor P; Ledertoug S; Boie S; Knoblauch NO; Stornes I
    BJOG; 2016 Jan; 123(1):129-35. PubMed ID: 26309128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin-ergometrine co-administration does not reduce blood loss at caesarean delivery for labour arrest.
    Balki M; Dhumne S; Kasodekar S; Kingdom J; Windrim R; Carvalho JC
    BJOG; 2008 Apr; 115(5):579-84. PubMed ID: 18333937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double blind, randomized trial on augmentation of labour with a combination of intravenous propranolol and oxytocin versus oxytocin only.
    Palomäki O; Uotila J; Tammela O; Kaila T; Lavapuro M; Huhtala H; Tuimala R
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):44-9. PubMed ID: 16051416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.